IDERA PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 6640
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 58197
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 31136
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 23102
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 268
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
C07K PEPTIDES 1135
 
  
 
C08B POLYSACCHARIDES; DERIVATIVES THEREOF 130

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0044,669 COMPOSITIONS FOR INHIBITING CHECKPOINT GENE EXPRESSION AND USES THEREOFOct 26, 17Feb 15, 18[A61K, C12N]
2018/0023,085 IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSEOct 06, 17Jan 25, 18[A61K, C12N]
2017/0145,412 COMPOSITIONS FOR INHIBITING NLRP3 GENE EXPRESSION AND USES THEREOFNov 02, 16May 25, 17[A61K, C12N]
2017/0009,230 COMPOSITIONS FOR INHIBITING DUX4 GENE EXPRESSION AND USES THEREOFJul 07, 16Jan 12, 17[A61K, C12N]
2016/0101,128 TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORSOct 09, 15Apr 14, 16[A61K]
2012/0016,004 COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOFMar 02, 11Jan 19, 12[A61K, C07H]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9828601 Compositions for inhibiting checkpoint gene expression and uses thereofFeb 25, 16Nov 28, 17[C07H, A61K, C12N]
9688993 Toll-like receptor 9 antagonist and methods of use thereofFeb 11, 16Jun 27, 17[C07H, A61K, C12N]
9540651 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseJul 06, 15Jan 10, 17[A61K, C12N]
9453228 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseDec 01, 15Sep 27, 16[A61K, C12N]
9260719 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseJan 08, 14Feb 16, 16[A61K, C12N]
9243050 Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8May 22, 14Jan 26, 16[A61K, C12N, C07K]
9206430 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseDec 31, 12Dec 08, 15[A61K, C12N]
9096858 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseMay 30, 13Aug 04, 15[A61K, C12N]
8987221 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (IRO) antagonists of TLR7 and TLR9Jun 01, 10Mar 24, 15[A61K, C12N]
8946175 Stabilized immunomodulatory oligonucleotidesAug 16, 11Feb 03, 15[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0233,741 IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSEAbandonedDec 01, 16Aug 17, 17[A61K, C12N]
2015/0044,196 Compositions for Inhibiting Gene Expression and Uses ThereofAbandonedSep 24, 14Feb 12, 15[A61K, C12N]
2012/0201,807 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDESAbandonedFeb 24, 12Aug 09, 12[A61K, C07H, A61P]
8202974 Synthetic RNA-based agonists of TLR7ExpiredFeb 10, 10Jun 19, 12[C07H, A61K, C12Q, A01N, C12N]
2012/0107,303 SYNERGISTIC TREATMENT OF CANCER USING IMMUNOMERS IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTSAbandonedJan 14, 11May 03, 12[A61K, A61P]
8153605 Modulation of toll-like receptor 3 expression by antisense oligonucleotidesExpiredAug 04, 09Apr 10, 12[C07H, C12Q, C12N]
8153608 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesExpiredNov 23, 10Apr 10, 12[C07H, A61K, A01N]
8153777 Modulation of toll-like receptor 5 expression by antisense oligonucleotidesExpiredNov 04, 09Apr 10, 12[C07H, A61K, C12N]
2011/0305,684 IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDESAbandonedMay 05, 10Dec 15, 11[A61K, A61P]
2011/0293,565 NOVEL SYNTHETIC AGONISTS OF TLR9AbandonedJan 28, 10Dec 01, 11[A61K, C07H, A61P]
8030462 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesExpiredOct 27, 03Oct 04, 11[C07H]
2011/0158,937 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPYAbandonedApr 09, 10Jun 30, 11[A61K, A61P]
2011/0135,669 SYNTHETIC AGONISTS OF TLR9AbandonedDec 03, 10Jun 09, 11[A61K, C07H, A61P]
2011/0082,186 COMPOSITIONS FOR INHIBITING GENE EXPRESSION AND USES THEREOFAbandonedAug 26, 10Apr 07, 11[C07H, A61K, A61P]
2011/0059,067 MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDESAbandonedNov 08, 10Mar 10, 11[A61K, A61P]
7884197 Synthetic agonists of TLR9ExpiredDec 12, 07Feb 08, 11[C07H, A61K, C12Q, A01N, C12N]
2011/0009,477 OLIGONUCLEOTIDE-BASED COMPOUNDS AS INHIBITORS OF TOLL-LIKE RECEPTORSAbandonedJul 08, 10Jan 13, 11[A61K, C07H, A61P]
7863250 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesExpiredJul 01, 05Jan 04, 11[C07H, A61K, A01N]
7851453 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesExpiredJan 14, 04Dec 14, 10[C07H, A61K, A01N]
7851454 Short immunomodulatory oligonucleotidesExpiredOct 24, 07Dec 14, 10[A61K, A01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.